2,011
Views
1
CrossRef citations to date
0
Altmetric
Clinical Study

Any heart failure treatments associated with worsening renal function in patients admitted due to acute heart failure?

, , , , & ORCID Icon
Pages 123-127 | Received 23 Apr 2020, Accepted 20 Nov 2020, Published online: 06 Jan 2021

References

  • Shirakabe A, Hata N, Kobayashi N, et al. Worsening renal function definition is insufficient for evaluating acute renal failure in acute heart failure. ESC Heart Fail. 2018;5(3):322–331.
  • Herout PM, Harshaw Q, Phatak H, et al. Impact of worsening renal function during hospital admission on resource utilization in patients with heart failure. Am J Cardiol. 2010;106(8):1139–1145.
  • Abo-Salem E, Sherif K, Dunlap S, et al. Potential aetiologies and prognostic implications of worsening renal function in acute decompensated heart failure. Acta Cardiol. 2014;69(6):657–663.
  • Ueda T, Kawakami R, Sugawara Y, et al. Worsening of renal function during 1 year after hospital discharge is a strong and independent predictor of all-cause mortality in acute decompensated heart failure. J Am Heart Assoc. 2014;3(6):e001174.
  • Damman K, Navis G, Voors AA, et al. Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. J Card Fail. 2007;13(8):599–608.
  • Cowie MR, Komajda M, Murray-Thomas T, et al. POSH Investigators. Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH). Eur Heart J. 2006;27(10):1216–1222.
  • Belziti CA, Bagnati R, Ledesma P, et al. Worsening renal function in patients admitted with acute decompensated heart failure: incidence, risk factors and prognostic implications. Rev Esp Cardiol. 2010;63(3):294–302.
  • Wen Z, Mai Z, Zhu X, et al. Comparison of renal impairment post-myocardial infarction with reduced and preserved left ventricular function in rats with normal renal function. Ren Fail. 2020;42(1):358–368.
  • Ponikowski P, Voors AA, Anker SD, ESC Scientific Document Group, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129–2200.
  • Ferreira JP, Chouihed T, Nazeyrollas P, et al. Practical management of concomitant acute heart failure and worsening renal function in the emergency department. Eur J Emerg Med. 2018;25(4):229–236.
  • Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;128(16):1810–1852.
  • Molnar AO, Petrcich W, Weir MA, et al. The association of beta-blocker use with mortality in elderly patients with congestive heart failure and advanced chronic kidney disease. Nephrol Dial Transplant. 2020;35(5):782–789.
  • Fukuta H, Goto T, Wakami K, et al. The effect of beta-blockers on mortality in heart failure with preserved ejection fraction: a meta-analysis of observational cohort and randomized controlled studies. Int J Cardiol. 2017;228:4–10.
  • Li SJ, Sartipy U, Lund LH, et al. Prognostic significance of resting heart rate and use of β-blockers in atrial fibrillation and sinus rhythm in patients with heart failure and reduced ejection fraction: findings from the Swedish Heart Failure Registry. Circ Heart Fail. 2015;8(5):871–879.
  • Matsushita K, Minamishima T, Sakata K, et al. Prognostic factors for one-year mortality in patients with acute heart failure with and without chronic kidney disease: differential impact of beta-blocker and diuretic treatments. Hypertens Res. 2019;42(7):1011–1018.
  • Li S, Li X. Prognostic significance of heart rate and beta-blocker use in sinus rhythm in patients with heart failure and preserved ejection fraction. High Blood Press Cardiovasc Prev. 2019;26(5):405–411.
  • Hall ME, Rocco MV, Morgan TM, et al. Beta-blocker use is associated with higher renal tissue oxygenation in hypertensive patients suspected of renal artery stenosis. Cardiorenal Med. 2016;6(4):261–268.
  • Hannedouche T, Brouard R, Godin M, et al. Chronic effects of tertatolol on renal function in hypertensive patients with mild chronic renal failure. Nephrol Dial Transplant. 1991;6(4):252–256.
  • Forman DE, Butler J, Wang Y, et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol. 2004;43(1):61–67.
  • Brazy PC, Stead WW, Fitzwilliam JF. Progression of renal insufficiency: role of blood pressure. Kidney Int. 1989;35(2):670–674.
  • Perneger TV, Nieto FJ, Whelton PK, et al. A prospective study of blood pressure and serum creatinine. Results from the 'Clue' Study and the ARIC Study. JAMA. 1993;269(4):488–493.
  • Kingkaew N, Antadech T. Cardiovascular risk factors and 10-year CV risk scores in adults aged 30-70 years old in Amnat Charoen Province, Thailand. Asia Pac J Sci Technol. 2019;24(4):APST-24-04-04.
  • Phitsanuwong C, Ariyanuchitkul S, Chumjan S, et al. Does hypertensive crisis worsen the quality of life of hypertensive patients with OSA: a pilot study. Asia Pac J Sci Technol. 2017;22(2):APST-22-02-01.
  • Jingmark S, Kuhirunyaratn P, Theeranut A, et al. Subjective well-being and related factors among community-dwelling elderly in Udon Thani Province, Thailand. Asia Pac J Sci Technol. 2020;25(1):APST-25-01-09.